Rezolute (RZLT) Long-Term Investments (2023 - 2025)
Rezolute's (RZLT) quarterly Long-Term Investments came in at $1.5 million in Q1 2025, down 4.64% year-on-year from $1.6 million in Q1 2024, and down 82.91% quarter-over-quarter from $8.8 million in Q4 2024.
Rezolute (RZLT) Long-Term Investments (2023 - 2025) Analysis & Trends
Rezolute has disclosed Long-Term Investments across 3 years of filings, most recently posting $1.5 million for Q1 2025.
- Long-Term Investments for Q1 2025 came in at $1.5 million, down 4.64% year-over-year; the trailing twelve-month figure through Mar 2025 was $1.5 million (down 4.64% YoY), and the FY2024 annual result was $263000.0, down 98.4% from the prior year.
- Long-Term Investments came in at $1.5 million for Q1 2025 at Rezolute, down from $8.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $26.2 million in Q1 2023 to a low of $263000.0 in Q2 2024.
- The 3-year median for Long-Term Investments is $8.1 million (2023), against an average of $8.4 million.
- Peak annual rise in Long-Term Investments reached 161.78% in 2024, while the deepest fall reached 98.4% in 2024.
- Rezolute's Long-Term Investments stood at $3.4 million in 2023, then jumped by 161.78% to $8.8 million in 2024, then plunged by 82.91% to $1.5 million in 2025.
- The last three Long-Term Investments figures came in at $1.5 million (Q1 2025), $8.8 million (Q4 2024), and $9.6 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Rezolute | 415.38 Mn | 415.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 8.78 Mn |
| Sep 30, 2024 | 9.55 Mn |
| Jun 30, 2024 | 263,000.00 |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 8.10 Mn |
| Jun 30, 2023 | 16.47 Mn |
| Mar 31, 2023 | 26.20 Mn |